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Bronchoscopy, Imaging, and Concurrent Diseases in Dogs
with Bronchiectasis: (2003–2014)
L.R. Johnson, E.G. Johnson, W. Vernau, P.H. Kass, and B.A. Byrne
Background: Bronchiectasis is a permanent and debilitating sequel to chronic or severe airway injury, however, diseases
associated with this condition are poorly defined.
Objective: To evaluate results of diagnostic tests used to document bronchiectasis and to characterize underlying or con-
current disease processes.
Animals: Eighty-six dogs that had bronchoscopy performed and a diagnosis of bronchiectasis.
Methods: Retrospective case series. Radiographs, computed tomography, and bronchoscopic findings were evaluated for
features of bronchiectasis. Clinical diagnoses of pneumonia (aspiration, interstitial, foreign body, other), eosinophilic bron-
chopneumopathy (EBP), and inflammatory airway disease (IAD) were made based on results of history, physical examina-
tion, and diagnostic testing, including bronchoalveolar lavage fluid analysis and microbiology.
Results: Bronchiectasis was diagnosed in 14% of dogs (86/621) that had bronchoscopy performed. Dogs ranged in age
from 0.5 to 14 years with duration of signs from 3 days to 10 years. Bronchiectasis was documented during bronchoscopy in
79/86 dogs (92%), thoracic radiology in 50/83 dogs (60%), and CT in 34/34 dogs (100%). Concurrent airway collapse was
detected during bronchoscopy in 50/86 dogs (58%), and focal or multifocal mucus plugging of segmental or subsegmental
bronchi was found in 41/86 dogs (48%). Final diagnoses included pneumonia (45/86 dogs, 52%), EBP (10/86 dogs, 12%)
and IAD (31/86 dogs, 36%). Bacteria were isolated in 24/86 cases (28%), with Streptococcus spp, Pasteurella spp, enteric
organisms, and Stenotrophomonas isolated most frequently.
Conclusions and Clinical Importance: Bronchiectasis can be anticipated in dogs with infectious or inflammatory respiratory
disease. Advanced imaging and bronchoscopy are useful in making the diagnosis and identifying concurrent respiratory
disease.
Key words: Bacterial; Computed tomography; COPD; Endoscopy; Microbiology; Parenchymal disease; Pneumonia;
Pulmonary infiltrates with eosinophilia; Radiology and diagnostic imaging; Respiratory tract.
Bronchiectasis is a condition characterized by pro-gressive and irreversible dilatation of the airways.1
Eosinophilic bronchopneumopathy (EBP) has been
commonly associated with bronchiectasis,2,3 along with
other diseases in dogs such as chronic bronchitis and
pneumonia.4–6 It is known to occur with primary ciliary
dyskinesia7 as well as Mycoplasma pneumonia8 and pul-
monary fibrosis.9 Bronchiectasis has also been reported
in cats with infectious, inflammatory, or neoplastic
disease,10,11 although its contribution to clinical signs is
unclear.
A comprehensive review of radiographically docu-
mented bronchiectasis in dogs revealed increased preva-
lence in Cocker spaniels and Miniature poodles, and
older dogs of various breeds were most commonly
affected.12 Progression of bronchiectasis and worsened
distribution of disease over time was noted in approxi-
mately half of the dogs in which follow-up radiographs
were available.12 However, recognition of bronchiectasis
is hampered by the poor sensitivity of radiographs,6
and in human medicine, high-resolution computed
tomography (CT) is the standard for diagnosis.13,14
Computed tomography features of bronchiectasis in the
dog have been described,6 and CT is increasingly used
to investigate respiratory diseases in dogs and cats,
although cost and the need for anesthesia preclude its
use in some situations.
Computed tomography provides structural informa-
tion on the airways and pulmonary parenchyma, how-
ever it does not allow documentation of cytologic and
microbiologic characteristics that identify the underlying
disease processes and guide treatment. In human medi-
cine, sputum cultures are used most frequently to con-
firm bacterial involvement in bronchiectasis15, however,
pharyngeal samples are not always accurate in dogs.16
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Bronchoscopy is utilized in referral hospitals to charac-
terize respiratory disease processes and provides valu-
able visual information to refine disease characteristics.
The purpose of this study was to evaluate results of
diagnostic tests used to document bronchiectasis,
including bronchoscopy, CT, and radiography. We also
sought to define underlying or concurrent disease pro-
cesses in affected dogs.
Materials and Methods
Medical records, imaging studies, and bronchoscopy reports
from dogs presented to the UC Davis William R. Pritchard Veteri-
nary Medical Teaching Hospital from 2003 through 2014 were
searched for identification of bronchiectasis. Inclusion criteria
included bronchoscopic characterization of airway dilatation with
or without suppuration or radiographic description of lack of nor-
mal airway tapering with or without pulmonary infiltrates. Com-
puted tomographic findings consistent with bronchiectasis12
including a bronchoarterial ratio >2.0 and lack of airway tapering
were also considered diagnostic of disease. Cases with histologic,
radiographic, or CT identification of bronchiectasis that did not
have bronchoscopy performed were not included in the analysis.
All bronchoscopic reports and available images or videos from
procedures were reviewed by a board certified internist (LRJ) to
confirm recognition of bronchiectasis. Radiographs (n = 83) and
CT images (n = 34) were reviewed by a board certified radiologist
(EGJ) for features consistent with bronchiectasis. The number of
affected dogs was compared to the total number of dogs in which
bronchoscopy was performed during the same time period.
Radiographs were usually performed the day before bron-
choscopy and no more than 1 week before the procedure. Laryn-
goscopy and assessment of upper airway anatomy preceded
anesthesia for CT or bronchoscopy in most cases. Laryngeal paresis
or paralysis was documented by failure of the cartilages to abduct
during appropriate respiratory effort at induction of anesthesia or
after stimulation of respiratory movements with doxapram
hydrochloride if required. Computed tomography was performed
immediately before bronchoscopy and the endoscopist was aware of
imaging results at the time of the procedure. Bronchoscopy was per-
formed by one of the authors (LRJ) or a clinician trained by the
author. Hyperemia, bronchiectasis with or without mucus plugging
of airways (Fig 1) and airway collapse were recorded.
Bronchoalveolar lavage (BAL) was performed at one or more
sites by instillation and aspiration of warm, sterile saline through
the biopsy channel of the endoscope. An aliquot of BALF was
submitted for microbial culture of aerobic bacterial species and
Mycoplasma spp. in all cases. In select cases, anaerobic bacterial
culture was also performed. Bacterial growth was assessed in a
semiquantitative fashion and reported as 1+, 2+, 3+, or 4+, desig-
nating the number of quadrants with bacterial growth. BAL fluid
from 6 healthy dogs consisted of 200 cells/lL, consisting mostly
macrophages, with less than 8% eosinophils, neutrophils, or lym-
phocytes.17 Alterations in percentage of inflammatory cells can
assist in characterization of respiratory disease, and BAL samples
were analyzed here by total and differential leukocyte counts
(based on a count of 200 cells). Cytologic assessment was made by
board certified clinical pathologists to document the presence of
oropharyngeal contaminants, intracellular bacteria, fungal ele-
ments, neoplasia, and foreign material.
Owner and referring veterinarian histories, medical records, and
radiographic findings along with VMTH records were comprehen-
sively reviewed by one of the authors (LRJ). Information abstracted
from the VMTH medical record included age, weight, breed, and
sex. Physical examination findings, results of imaging, bron-
choscopy, BALF cytology, and microbiology along with response to
treatment (where available) were used to identify previous respira-
tory diagnoses and the most likely underlying or concurrent disease
processes associated with bronchiectasis in each dog.
Inflammatory airway disease was diagnosed in systemically
healthy dogs that lacked radiographic evidence of pneumonia, had
BALF that contained >8% neutrophils or lymphocytes, or a mixed
inflammatory cytologic pattern that lacked intracellular bacteria,
and had no growth of potential pathogens on microbial culture.
Eosinophilic bronchopneumopathy was diagnosed in dogs that
were negative for heartworm, negative for lungworm or failed fen-
bendazole trial, demonstrated bronchoscopic findings of yellow
mucus, airway collapse, or hyperemia,2 and had a high percentage
of BAL eosinophils. Steroid responsive was also documented.
Final diagnoses of pneumonia included infectious, aspiration, for-
eign body, or interstitial pneumonia. When any number of neu-
trophils in BALF contained intracellular bacteria or culture
revealed growth of potentially pathogenic bacteria, the sample was
categorized as septic and infectious pneumonia was diagnosed.
Historical reports of predisposing risk factors along with radio-
graphic findings consistent with aspiration18 were used in charac-
terizing pneumonia related to aspiration; positive bacterial growth
from BALF was not a criterion for this diagnosis. Interstitial
pneumonia was diagnosed by characteristic findings on CT or
histopathology. A diagnosis of foreign body pneumonia was
assigned to dogs that had foreign material removed from the lung.
Statistics
Age, duration of signs, and weight were evaluated for compati-
bility with a normal distribution using the D’Agostino & Pearson
A B
Fig 1. Bronchoscopic images from 2 dogs with bronchiectasis with (A) and without (B) suppuration.
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omnibus normality test. Data were not normally distributed and
are presented as median and range. The exact Kruskal–Wallis test
was used to compare distributions of continuous variables between
groups; when significant, posthoc exact Mann–Whitney tests with
a Bonferroni–Holm multiple comparison adjustment were used.
The distribution of affected breeds was compared to the breed dis-
tribution of the hospital population using an exact chi-square test
of homogeneity because many expected cell frequencies were less
than five. Breeds overrepresented in the affected group were identi-
fied based on significantly contributing to the overall chi-square
test statistic; results are presented as observed:expected ratios. The
exact chi-square test of homogeneity was used to assess difference
in the detection of airway collapse, hyperemia, mucus plugging,
and radiographically or bronchoscopically visible bronchiectasis
among disease groups; posthoc pairwise comparisons were per-
formed with a Bonferroni–Holm multiple comparison adjustment.
Statistics were performed using commercially available software.a
Statistical significance was defined as P < .05.
Results
From April 2003 through April 2014, bronchiectasis
was documented in 86/621 dogs (14%) that had bron-
choscopy performed. Bronchiectasis was diagnosed
bronchoscopically in 79/86 (92%) dogs, by thoracic
radiology in 50/83 dogs (60%) and by CT in 34/34 dogs
(100%). Diagnosis of bronchiectasis was concordant by
all 3 methods in 15/34 dogs (44%), however, radio-
graphs did not show bronchiectasis in 13/34 cases
(38%). (Fig 2) Computed tomography revealed that
bronchiectasis was diffuse in 19/34 dogs, multifocal in
13/34 dogs, or focal in 2/34 dogs. Bronchoscopy
revealed airway hyperemia in 58/86 dogs (67%), focal
or multifocal mucus plugging of segmental or subseg-
mental bronchi in 41/86 dogs (48%), and concurrent
airway collapse in 50/86 dogs (58%).
Final diagnoses in dogs with bronchiectasis included
pneumonia in 45/86 dogs (52%), EBP in 10/86 dogs
(12%) and IAD in 31/86 dogs (36%). Differential cyto-
logic findings in these groups of dogs are presented in
Table 1. Multiple lung lobes were sampled in 85/86
dogs and BAL results from the specific site of
bronchiectasis were reported in 57/86 (66%) dogs. In
the remaining 29 dogs, BAL results were averaged when
similar values were obtained or values from the more
cellular sample were reported. A low cell count (<300
cells/lL) did not result in exclusion from analysis when
all other clinical data were available.
(A)
(C)
(B)
Fig 2. (A and B) Right lateral and dorsoventral radiographs from a dog subsequently diagnosed with diffuse bronchiectasis based on CT
and bronchoscopy. Thoracic radiographs reveal mild bronchial wall mineralization, heterotopic bone formation, and mild interstitial pul-
monary densities compatible with normal age-related changes. Bronchiectasis is not identified. (C) Computed tomographic images from the
dog in 2A and B. Heavy alveolar infiltrates are present in the ventral aspects of the right cranial, and right middle lung lobes, as well as
the caudal subsegment of the left cranial lung lobe. In these images, bronchi to the right cranial and right middle lobes are moderately
dilated, and do not taper appropriately.
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Affected dogs ranged in age from 0.5 to 14 years (me-
dian 10 years) with 1/86 dogs < 6 months, 16/86 dogs
(19%) 1–5 years of age, 37/86 dogs (43%) 5.1–10 years
of age, and 32/86 dogs (37%) over 10 years of age.
Weights of affected dogs ranged from 2 to 49.2 kg with
a median of 17 kg. Small dogs (<5 kg) comprised 11/84
(13%) dogs, 27/84 dogs (32%) were 5–15 kg, 35/84
dogs (42%) were 15.1–35 kg, and 11/84 dogs (13%)
were >35 kg. Weight was not recorded in 2 dogs.
Cough was the primary complaint in 81/86 (94%) dogs,
while respiratory difficulty or tachypnea was reported in
5/86 (6%). Duration of cough ranged from 3 days to
10 years, with a median of 6 months.
Demographics for dogs in the various disease groups
associated with bronchiectasis are presented in Table 2.
The distribution of ages of dogs with specific diseases
differed significantly among groups, although none of
the pairwise age differences between groups were signifi-
cant after multiple comparison adjustment. Body weight
of dogs with specific diseases differed significantly
among groups (P = .001); weight of dogs with pneumo-
nia was significantly greater than that of dogs with IAD
(P = .0003). Duration of cough did not differ among
groups (P = .091), with median values of 4, 6, and
8.5 months in dogs with pneumonia, EBP, and IAD,
respectively.
There was a significant difference in the distribution
of breeds between dogs affected with bronchiectasis and
other dogs seen at the hospital (P = .0002). Dog breeds
affected more than twice included 6 Labrador retrievers,
5 Cocker spaniels, 4 Golden retrievers, and 4 Standard
Poodles, and 3 each of the Beagle, Chihuahua, Pug,
and Malamute. Compared to the hospital population,
the following breeds could be overrepresented, although
some were represented by only one case: Airedale (1),
Malamute (3), American Eskimo (2), Beagle (3), Belgian
Tervuren (1), Cocker Spaniel (5), Rough-coated Collie
(1), Long-haired miniature Dachshund (1), Flat-coated
retriever (1), Miniature Pinscher (2), Patterdale terrier
(1), Standard poodle (5), Shetland Sheepdog (2), Soft-
coated Wheaten (1), and West Highland White terrier
(2). (Table 3).
Pneumonia concurrent with bronchiectasis was recog-
nized in 45/86 (52%) dogs. Aspiration pneumonia was
suspected in 25/45 dogs, with laryngeal paralysis in 7 of
these dogs and elongated soft palate in 3 of these dogs
as potential contributing factors. Interstitial pneumonia
was diagnosed in 6 dogs based on CT (n = 4) and
histopathology (n = 4), with inhalational injury sus-
pected in 3/6 dogs and interstitial fibrosis in 2/6 dogs
(both West Highland white terriers). Previous foreign
body impaction was documented in 3/45 dogs with
pneumonia. In the remaining 11 dogs, no specific
underlying trigger or concurrent cause for pneumonia
was identified, with infection documented in 9 of these
cases.
Active infection was documented at the time of
diagnosis with bronchiectasis in 22/45 dogs (49%) with
pneumonia including 12/25 with aspiration, 1/6 with
interstitial pneumonia, 0/3 with foreign body pneumo-
nia, and 9/11 with an unrecognized cause of pneumo-
nia. The most commonly isolated bacterium (n = 7) was
Streptococcus, with Streptococcus canis in 4 dogs and
Streptococcus viridans, Streptococcus equi spp. zooepi-
demicus, and an untyped Streptococcus in 1 dog each.
Enteric organisms were isolated in 5 cases (E. coli in 4
dogs and Klebsiella pneumonia in 1 dog). Nonenteric
bacteria were also isolated including Pasteurella spp. in
4 dogs, Stenotrophomonas maltophilia in 3 dogs, and
Bordetella bronchiseptica in 2 dogs. Other isolates
included Pseudomonas aeruginosa, Actinomyces spp.,
and Capnocytophagia cynodegmi in 1 dog each. More
than one species of bacteria was isolated in 5/21
cases. Concurrent with aerobic bacterial isolation,
Mycoplasma culture was positive in 3/21 cases, an
anaerobe (Fusobacterium nucleatum) was isolated in 1/
Table 1. Cell counts and differential cytology results in dogs with pneumonia, eosinophilic bronchopneumopathy
and inflammatory airway disease. Table entries represent median values with range (in parentheses).
Pneumonia Eosinophilic Bronchopneumopathy Inflammatory Airway Disease
BAL total cell count/lL 1310 (120–39,440) 1300 (340–14,040) 670 (240–6200)
Neutrophils (%) 52 (3–99) 42 (2–70) 24 (1–91)
Lymphocytes (%) 6 (0–42) 3 (0–9) 11 (0–52)
Macrophages (%) 36 (1–90) 6 (1–44) 61 (2–85)
Eosinophils (%) 3 (1–15) 44 (27–70) 3 (0–16)
Table 2. Demographic data for dogs with bronchiectasis. Table entries represent median values with ranges and P
values represent comparisons among disease groups. Significant (P < .05) pairwise group differences test using Mann
–Whitney tests and a Bonferroni–Holm posthoc multiple comparison adjustment after a significant Kruskal–Wallis
are represented by*.
Pneumonia Eosinophilic Bronchopneumopathy Inflammatory airway Disease P Value
Age (years) 9.2 (0.5–13.1) 9.0 (3.0–12.0) 10.0 (1.5 – 14.0) .044
Weight (kg) 25.6 (3.6–49.2)* 16.0 (4.6–38.0) 10.4 (2.0–47.7)* .001*
Duration of cough (months) 4.0 (0.1–48) 6.0 (2.5–60) 8.5 (1.0–120) .091
M/F 21/24 4/6 10/18 .088
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21 cases, and fungal culture was positive for Aspergillus
terreus in 1/1 dog tested.
Computed tomography was performed in 27 of 45
dogs with pneumonia and revealed findings consistent
with bronchiectasis in all. Distribution of bronchiectasis
was diffuse in 13, multifocal in 12, and focal in 2 dogs.
Thoracic radiography demonstrated bronchiectasis in
19/44 dogs (43%) with pneumonia. Bronchoscopic evi-
dence of airway dilatation was reported in 41/45 dogs
(91%), and concurrent airway collapse was diagnosed
in 19/45 dogs (42%).
Eosinophilic bronchopneumopathy was diagnosed in
10/86 (12%) dogs. Mean eosinophil percentage was
43.5  13.2%. Two of these 10 dogs had concurrent
airway infection, with isolation of Pseudomonas
aeruginosa and Pasteurella canis in one dog each. No
Mycoplasma spp. or anaerobes were isolated. Computed
tomography revealed diffuse bronchiectasis in 4/4 dogs
evaluated, and radiographs demonstrated airway dilata-
tion in 8/10 dogs. Bronchoscopic evidence of bronchiec-
tasis was noted in 9/10 dogs, and concurrent airway
collapse was documented in 8/10 dogs.
Inflammatory airway disease was the final diagnosis
in 31/86 dogs (36%) with concurrent airway collapse in
23/31 dogs (74%). Computed tomography revealed dif-
fuse bronchiectasis in 2/3 dogs and multifocal disease in
1/3 dogs. Radiographic findings consistent with
bronchiectasis were reported in 16/30 dogs (53%).
Bronchoscopically, airway dilatation was reported in
29/31 dogs.
Detection of bronchiectasis by radiography or bron-
choscopy did not differ significantly among disease
groups (P = .33 and P = 1.0, respectively). However,
bronchoscopic evidence of airway collapse was signifi-
cantly different among disease groups (P = .0065), being
present in a significantly lower percentage of dogs with
pneumonia (42%) than in those with EBP (80%) or
IAD (74%), P value = .0094. Mucus plugging of air-
ways differed significantly among disease groups
(P = .036), but no pairwise differences were significant
after multiple comparison adjustment. (Table 4).
Discussion
This study identified bronchiectasis with radiographs,
computed tomography, bronchoscopy, or a combina-
tion of tests in 86/621 dogs (14%) that had
bronchoscopy performed over an 11 year period. Con-
current diseases found in dogs with bronchiectasis
included various types of pneumonia and inflammatory
airway disease associated with eosinophilic, neu-
trophilic, or lymphocytic infiltration. Although
bronchiectasis is reportedly a rare condition when
affected cases are compared to the total hospital popu-
lation,12 results obtained here indicate that it is a
relatively common finding in dogs evaluated specifically
for respiratory disease.
In human medicine, bronchiectasis develops in adults
10–20 years after the pulmonary insult,15 although the
onset varies and children as young as 8 months of age
can also be affected.19 Duration of signs in dogs exam-
ined here was similar to that reported in a previous
study,12 and in 23% of dogs, clinical signs had been
Table 3. Breeds that were significantly more likely to
demonstrate bronchiectasis at the UCD VMTH. The
observed:expected (O:E) ratio provides a comparison of
the number of affected dogs for a particular breed in
relation to the expected number of cases for that breed
based on the distribution of all breeds seen at the
VMTH during the time frame of this study. P value
corresponds to the null hypothesis that the O:E
ratio = 1 and is calculated from the breed’s cell-specific
chi-square contribution for bronchiectasis diagnosis to
the overall chi-square test statistic for all breeds.
Breed
Number
Affected
Observed:
Expected
Ratio P Value
Airedale terrier 1 5.8 .046
Alaskan Malamute 3 15.1 .0001
American Eskimo dog 2 10.2 .0014
Beagle 3 3.3 .029
Belgian Tervuren 1 19.7 <.0001
Cocker Spaniel 5 4.7 .0001
Rough Collie 1 5.9 .043
Long haired mini-Dachshund 1 10.9 .0027
Flat coated retriever 1 7.9 .014
Miniature Pinscher 2 3.9 .036
Patterdale terrier 1 90.7 <.0001
Standard Poodle 5 7.7 <.0001
Shetland Sheepdog 2 3.8 .043
Soft coated Wheaten terrier 1 7.0 .024
West Highland white terrier 2 4.2 .027
Table 4. Comparison among disease groups for the prevalence rates of radiographic and bronchoscopic findings.
Table entries represent the number and percentage of affected dogs in each disease group. Significant (P < .05) pair-
wise group differences using a Bonferroni–Holm posthoc multiple comparison adjustment after a significant chi-
square test are represented by columns sharing*.
Pneumonia
Eosinophilic
Bronchopneumopathy Inflammatory Airway Disease P Value
Radiographically visible bronchiectasis 26/43 (60%) 8/10 (80%) 16/30 (53%) .33
Bronchoscopic evidence of airway dilatation 41/45 (91%) 9/10 (90%) 29/31 (94%) 1.0
Airway collapse on bronchoscopy 19/45 (42%)* 8/10 (80%) 23/31 (74%)* .0065*
Moderate to severe airway hyperemia 33/45 (73%) 5/10 (50%) 20/31 (65%) .35
Mucus plugging of airways 26/45 (58%) 6/10 (60%) 9/31 (29%) .036
Bronchiectasis in Dogs 251
present for <2 months. This suggests that ongoing lung
disease with irreversible damage is occurring in the
absence of owner-recognized clinical signs or of physical
examination abnormalities that could be detected during
a routine veterinary visit, a situation similar to that found
in children.19 Recognition of the disorder is made more
difficult by the finding that radiographs detected less than
2/3 of cases, similar to an earlier investigation.6
In this study, bronchoscopy was highly useful in doc-
umenting bronchiectasis, with identification of 92% of
affected dogs. In human medicine, bronchoscopy is used
only when a foreign body is suspected, when aspiration
is presumed, or when atypical bacterial or mycobacte-
rial infection is considered likely.13,15,20 However, in
certain populations, bronchoscopy is more sensitive for
detecting airway pathology than high-resolution
computed tomography and both tests are advised for
evaluation of children with wet cough.21 In this study,
8% of bronchoscopy procedures did not document
bronchiectasis possibly because of the inability of the
endoscope to access more peripheral airways or because
of mucus plugging that obscured visualization. Clearly
performing both CT and bronchoscopy is preferred for
complete evaluation of the lungs, but this study
confirms the utility of bronchoscopy in identifying air-
way dilatation as well as additional findings within the
airways.
In dogs with bronchiectasis examined here, pneumo-
nia was the most common disease process, with most
dogs suffering from probable aspiration pneumonia.
Development of bronchiectasis in aspiration pneumonia
can be readily explained, particularly if chronic aspira-
tion is considered likely, as in dogs with laryngeal
paralysis or upper airway obstruction. Acid injury and
bacterial infection both contribute to airway injury and
inflammation which could initiate the processes leading
to degradation of the support structures of the lung and
airway dilatation.22–25 Silent aspiration is a common
problem in human medicine and might also occur in
dogs, as clinical signs in animals could readily go unrec-
ognized. Vomiting, regurgitation, and swallowing
disorders are common in dogs,26 but the occurrence of
bronchiectasis in that population of dogs is unknown.
Further studies are needed as up to 2/3 of pediatric
patients with chronic aspiration injury develop
bronchiectasis.19
Regardless of the underlying etiology, the pathophysi-
ologic consequences of bronchiectasis are similar.
Epithelial cell injury and loss of normal mucociliary
transport result in trapping of potential pathogens and
environmental particulate matter in the lower airways
that can perpetuate airway injury and further infection.
Bacterial infection plays a central role in human cases
of bronchiectasis,14,24 however, only 24/86 dogs (28%)
had positive bacterial cultures here, despite this
increased risk for infection. Previous use of antibiotics
could explain the low number of infections documented,
however, this was not examined here, and a previous
study showed that bacteria could be isolated from many
dogs despite antimicrobial administration.27 It has been
reported that recognition of bacteria in the lower
airways can require culture-independent mechanisms for
detection.25,28 We have previously reported culture-
based isolation of bacteria from 89/105 dogs with lower
respiratory tract infection,27 however, PCR-based
techniques can identify substantially more bacterial
species.24,28,29 Further investigations are needed to con-
firm or deny a role for specific bacteria in dogs with
bronchiectasis.
Bacterial isolates from some dogs with bronchiectasis
were included in a previous study of lower respiratory
tract infection in dogs,27 however, it is interesting to
note the number of opportunistic pathogens associated
with infection in dogs with bronchiectasis examined
here, particularly Stenotrophomonas, Pseudomonas, and
Capnocytophaga. It was not possible to estimate the
duration of active infection in dogs with bacteria iso-
lated and it is unknown whether bacteria were a cause
or a result of bronchiectasis. Isolation of Pseudomonas
spp, Haemophilus, and Mycobacterium avium is
common in human medicine,15,28 and Stenotrophomonas
has been increasingly recognized in both cystic fibrosis
and noncystic fibrosis bronchiectasis.30 Infection with
Pseudomonas spp. is often particularly difficult to eradi-
cate from the lung and contributes to further airway
injury through induction of chronic inflammation.15,24
In a previous study of dogs with radiographically
identified bronchiectasis, neutrophilic, and eosinophilic
inflammation was common, along with positive bacte-
rial cultures,12 however, specific disease categories were
not defined. Our finding of bronchiectasis in inflamma-
tory airway diseases of dogs should not be surprising
given that the pathophysiology of bronchiectasis is
thought to be related to enzymatic products of inflam-
matory cells and aberrant cytokine responses,23,31
although the relatively rare occurrence of bronchiectasis
(2%) in the inflammatory condition of human asthma
raises questions about the exact mechanisms of develop-
ment.14 Response of the canine lung to chronic
inflammation could be more similar to that found in
the cat, where 17% of cases (4 of 23 cats) with bronchi-
tis/asthma had bronchiectasis documented on
bronchoscopy.11 It is possible that IAD in the dog more
closely resembles the human condition of chronic
obstructive pulmonary disease, a composite of emphy-
sema and chronic bronchitis, in which up to 50% of
patients can demonstrate bronchiectasis.32,33
The relationship between bronchiectasis and airway
collapse in veterinary medicine is unclear. A previous
study reported bronchiectasis in 30% of dogs with
tracheal collapse.34 However, both conditions were
diagnosed solely by review of thoracic radiography,
which likely overdiagnosed tracheal collapse and under-
diagnosed bronchiectasis. Bronchomalacia was docu-
mented in 11 of 33 children with bronchiectasis.35 In
dogs with radiographically evident bronchiectasis, fluo-
roscopic evidence of airway collapse was found in 9/10
dogs examined and was visualized bronchoscopically in
4/6 dogs.12 However, in a report on bronchomalacia in
dogs, <10% of dogs had bronchoscopic evidence of
bronchiectasis and an equivalent number of dogs
without bronchomalacia also had bronchiectasis.36
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Fluoroscopy was not evaluated in the present study,
although bronchoscopy identified a relatively high
percentage of airway collapse (58%), with a higher
prevalence in dogs with inflammatory airway disease
than in dogs with pneumonia. It has been suggested
that airway inflammation could potentiate airway
collapse. Given that bronchiectasis is associated with
loss of structural support within the airways, increased
collapsibility might be anticipated, as was demonstrated
in one study of human patients.37 However, some cases
of bronchiectasis demonstrated a rigid appearance of
the airways rather than collapse. (Fig 1B) Whether
these are cases of traction bronchiectasis or cases that
lack a strong inflammatory component that could
enhance the likelihood of collapse requires further
study.
Multiple breeds were affected by bronchiectasis and
this study confirms the susceptibility of Cocker spaniels
(n = 5) noted previously.11 Interestingly, Malamutes
(n = 3) were possibly overrepresented, but had bronch-
iectasis in association with inflammatory rather than
with eosinophilic airway disease, which has been previ-
ously reported.2 In addition, several other breeds were
overrepresented here in relation to the hospital popula-
tion. Rare breeds such as the Airedale and Patterdale
terrier were possibly overrepresented compared to the
hospital population despite diagnosis of bronchiectasis
in only 1 dog of each breed. This raises the question of
genetic propensity to development of bronchiectasis in
certain breeds. However, these findings (and those of
Table 4) must be interpreted with caution in light of the
small numbers of dogs diagnosed with bronchiectasis
within each of the breeds.
Multiple clinicians were involved in bronchoscopic
reports and potential inconsistency in documentation
represents one limitation of the study. Also, bronchiec-
tasis can develop with age in healthy dogs, which could
result in over diagnosis of the disorder in older dogs.38
Other limitations arise from the reliance on owner his-
tory for an accurate depiction of events. In some dogs,
a long-term history of respiratory disease was reported,
and it was not possible to identify the precise onset of
clinical disease. Alternately, while some owners
described an acute onset of signs, it is possible that ear-
lier clinical signs might have gone unrecognized.
Finally, BAL samples were not always obtained from
the region affected by bronchiectasis, and the impact of
antibiotic or steroid administration on cell counts and
differential cytology was not considered in this study.
Although BALF analysis was only one criterion used in
defining the final respiratory diagnosis, this represents
an important consideration when interpreting results of
this study.
The prevalence of bronchiectasis in human medicine
has drastically decreased in recent years with more
appropriate antibiotic usage but it remains a significant
problem in developing countries. This study suggests
that bronchiectasis is relatively common in dogs that
require specialized diagnostics such as CT or
bronchoscopy for identification of disease, as indicated
by detection of bronchiectasis in 14% of dogs that had
bronchoscopy performed. Given the presumed
irreversibility of bronchiectasis and the need for long-
term management of airway secretions and infection,
enhanced understanding of disease associations and
early recognition of bronchiectasis should allow better
patient care. Therefore, dogs with chronic signs associ-
ated with pneumonia, EBP, or IAD should be consid-
ered at risk for bronchiectasis, and advanced imaging
followed by bronchoscopy should be recommended.
While both computed tomography and bronchoscopy
can provide structural information, bronchoscopy
has the advantage of identifying airway collapse as
well as allowing collection of airway samples to direct
treatment.
Footnote
a GraphPad Prism Version 5, San Diego, CA and Stata/IC 1.31,
StatCorp LP, College Station, TX.
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